Dyne Therapeutics, Inc. - COM (DYN)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
14.8K
Holdings value Q3 2024
$533K
Value change Q3 2024
+$533K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
1
Number of buys Q3 2024
1
Number of sells Q3 2024
0
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 14.8K $533K +$533K $35.92 1
2018 Q3 0 $0 -$4K 0
2018 Q2 275 $4K -$2.14B $14.55 1
2018 Q1 158M $2.14B -$97.9M $13.52 161
2017 Q4 168M $1.99B +$272M $11.85 170
2017 Q3 146M $1.43B +$5.18M $9.79 170
2017 Q2 147M $1.22B -$11.6M $8.27 156
2017 Q1 149M $1.17B +$246M $7.86 166
2016 Q4 134M $1.13B -$148M $8.46 169
2016 Q3 136M $1.69B +$5.88M $12.39 158
2016 Q2 129M $2.23B +$229M $17.24 170
2016 Q1 115M $1.66B -$147M $14.37 155
2015 Q4 128M $1.72B -$405M $13.40 161
2015 Q3 141M $2.91B -$23.9M $20.67 175
2015 Q2 136M $3.99B +$196M $29.25 199
2015 Q1 130M $4.08B +$100M $31.43 177
2014 Q4 126M $3.82B +$719M $30.35 169
2014 Q3 103M $2.96B +$139M $28.86 149
2014 Q2 97.1M $3.38B -$32.3M $34.80 150
2014 Q1 98.6M $2.46B -$18.3M $24.94 107